Prasugrel News and Research

RSS
Platelet function testing in elderly patients after heart attack shows no improved outcomes

Platelet function testing in elderly patients after heart attack shows no improved outcomes

Pre-procedural use of antiplatelet therapy becoming less routine in heart attack treatment

Pre-procedural use of antiplatelet therapy becoming less routine in heart attack treatment

Younger women more likely to experience one-year adverse cardiovascular events after PCI

Younger women more likely to experience one-year adverse cardiovascular events after PCI

Treatment with antiplatelet therapy does not reduce pain crises in children with sickle cell disease

Treatment with antiplatelet therapy does not reduce pain crises in children with sickle cell disease

DAPT Study shows dual antiplatelet therapy reduces bleeding-related mortality

DAPT Study shows dual antiplatelet therapy reduces bleeding-related mortality

Prasugrel linked to high-bleeding-risk in patients with stable coronary artery disease

Prasugrel linked to high-bleeding-risk in patients with stable coronary artery disease

Radial approach superior than femoral one for coronary angiography and PCI for ACS patients

Radial approach superior than femoral one for coronary angiography and PCI for ACS patients

Health Canada to review evidence on the safety of long-term use of prescription blood-thinners

Health Canada to review evidence on the safety of long-term use of prescription blood-thinners

Pre-treatment with prasugrel increases risk of bleeding without reducing risk of ischemic events

Pre-treatment with prasugrel increases risk of bleeding without reducing risk of ischemic events

Older heart patients present unique challenges for determining optimal dosages of medications

Older heart patients present unique challenges for determining optimal dosages of medications

Study: New genetic marker predicts warfarin dose in African-Americans

Study: New genetic marker predicts warfarin dose in African-Americans

TRILOGY-ACS platelet function substudy results revealed

TRILOGY-ACS platelet function substudy results revealed

Most patients taking common blood-thinning drugs may be receiving wrong dosage levels

Most patients taking common blood-thinning drugs may be receiving wrong dosage levels

Cause of heart attacks or strokes may be different in some patients treated with anti-platelet drugs

Cause of heart attacks or strokes may be different in some patients treated with anti-platelet drugs

Prasugrel reduces cardiovascular events among patients managed medically for ACS

Prasugrel reduces cardiovascular events among patients managed medically for ACS

MADONNA: Personalized antiplatelet therapy savior for angioplasty patients?

MADONNA: Personalized antiplatelet therapy savior for angioplasty patients?

AstraZeneca’s ticagrelor receives Class I recommendation from ESC

AstraZeneca’s ticagrelor receives Class I recommendation from ESC

Personalized antiplatelet treatment leads to better outcomes in patients undergoing PCI

Personalized antiplatelet treatment leads to better outcomes in patients undergoing PCI

Prasugrel as safe as clopidogrel in preventing heart attack, stroke and death

Prasugrel as safe as clopidogrel in preventing heart attack, stroke and death

HCRI announces successful completion of randomization in DAPT Study

HCRI announces successful completion of randomization in DAPT Study